Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants
Condition(s):Virus, Zika; Zika Virus Disease; Flavivirus Infections; Healthy ParticipantsLast Updated:February 11, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Virus, Zika; Zika Virus Disease; Flavivirus Infections; Healthy ParticipantsLast Updated:February 11, 2022Completed
Condition(s):Zika Virus Disease (Disorder)Last Updated:August 19, 2021Completed
Condition(s):Zika Virus; Dengue Virus; Chikungunya Virus InfectionsLast Updated:March 18, 2019Completed
Condition(s):VirusesLast Updated:November 10, 2020Completed
Condition(s):Zika Virus Infection; MicrocephalyLast Updated:May 7, 2019Completed
Condition(s):HIV; Zika Virus; Pregnant WomenLast Updated:January 14, 2022Completed
Condition(s):Treatment of Acute Zika Virus InfectionLast Updated:April 10, 2019Completed
Condition(s):Zika Virus InfectionLast Updated:October 22, 2020Completed
Condition(s):Zika; Neurodevelopmental Abnormality; Hearing Loss; Growth Delay; Eye AbnormalitiesLast Updated:April 22, 2022Completed
Condition(s):Zika Virus; Zika Virus Infection; Virus Diseases; Flavivirus Infections; Flaviviral Diseases; Flaviviridae Infections; RNA Virus InfectionsLast Updated:January 31, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.